Alternative lengthening of telomeres-An enhanced chromosomal instability in aggressive non-MYCN amplified and telomere elongated neuroblastomas

Genes Chromosomes and Cancer

Volumn 50, Issue 4, 2011, Pages 250-262

  Lundberg, Gisela ^a   Sehic, Daniel ^a   Länsberg, John Kalle ^b   øra, Ingrid ^b,c   Frigyesi, Attila ^b   Castel, Victoria ^d   Navarro, Samuel ^e   Piqueras, Marta ^e   Martinsson, Tommy ^f   Noguera, Rosa ^e   Gisselsson, David ^a,b  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d HOSPITAL UNIVERSITARIO LA FE   (Spain)

^e UNIVERSITY OF VALENCIA   (Spain)

^f UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AMPLICON; ANAPHASE; ARTICLE; CHILD; CHROMOSOMAL INSTABILITY; CHROMOSOME SEGREGATION; CONTROLLED STUDY; FEMALE; GENE AMPLIFICATION; GENE SEQUENCE; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT; MALE; NEUROBLASTOMA; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; TELOMERE; TUMOR CELL;

ADULT; ANAPHASE; CELL LINE, TUMOR; CHILD; CHILD, PRESCHOOL; CHROMOSOMAL INSTABILITY; FEMALE; GENE AMPLIFICATION; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INFANT; INFANT, NEWBORN; MALE; NEUROBLASTOMA; NUCLEAR PROTEINS; ONCOGENE PROTEINS; TELOMERASE; TELOMERE; YOUNG ADULT;

EID: 79851490466     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20850     Document Type: Article

References (53)

1. Ambros PF, Ambros IM. 2001. Pathology and biology guidelines for resectable and unresectable neuroblastic tumors and bone marrow examination guidelines. Med Pediatr Oncol 37: 492-504.
2. Artandi SE, Chang S, Lee SL, Alson S, Gottlieb GJ, Chin L, DePinho RA. 2000. Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature 406: 641-645.
3. Attiyeh EF, London WB, Mossé YP, Wang Q, Winter C, Khazi D, McGrady PW, Seeger RC, Look AT, Shimada H, Brodeur GM, Cohn SL, Matthay KK, Maris JM. 2005. Chromosome 1p and 11q deletions and outcome in neuroblastoma. N Engl J Med 353: 2243-2253.
4. Avigad S, Naumov I, Ohali A, Jeison M, Berco GH, Mardoukh J, Stark B, Ash S, Cohen IJ, Meller I, Kollender Y, Issakov J, Yaniv I. 2007. Short telomeres: A novel potential predictor of relapse in Ewing sarcoma. Clin Cancer Res 13: 5777-5783.
5. Bazarov AV, Hines WC, Mukhopadhyay R, Beliveau A, Melodyev S, Zaslavsky Y, Yaswen P. 2009. Telomerase activation by c-Myc in human mammary epithelial cells requires additional genomic changes. Cell Cycle 8: 3373-3378.
6. Bechter OE, Eisterer W, Pall G, Hilbe W, Kuhr T, Thaler J. 1998. Telomere length and telomerase activity predict survival in patients with B cell chronic lymphocytic leukemia. Cancer Res 58: 4918-4922.
7. Bell E, Lunec J, Tweddle DA. 2007. Cell cycle regulation targets of MYCN identified by gene expression microarrays. Cell Cycle 6: 1249-1256.
8. Bignell GR, Santarius T, Pole JC, Butler AP, Perry J, Pleasance E, Greenman C, Menzies A, Taylor S, Edkins S, Campbell P, Quail M, Plumb B, Matthews L, McLay K, Edwards PA, Rogers J, Wooster R, Futreal PA, Stratton MR. 2007. Architectures of somatic genomic rearrangement in human cancer amplicons at sequence-level resolution. Genome Res 17: 1296-1303.
9. Binz N, Shalaby T, Rivera P, Shin-ya K, Grotzer MA. 2005. Telomerase inhibition, telomere shortening, cell growth suppression and induction of apoptosis by telomestatin in childhood neuroblastoma cells. Eur J Cancer 41: 2873-2881.
10. Brachner A, Sasgary S, Pirker C, Rodgarkia C, Mikula M, Mikulits W, Bergmeister H, Setinek U, Wieser M, Chin SF, Caldas C, Micksche M, Cerni C, Berger W. 2006. Telomerase- and alternative telomere lengthening-independent telomere stabilization in a metastasis-derived human non-small cell lung cancer cell line: Effect of ectopic hTERT. Cancer Res 66: 3584-3592.
11. Brodeur GM, Sekhon G, Goldstein MN. 1977. Chromosomal aberrations in human neuroblastomas. Cancer 40: 2256-2263.
12. Brodeur GM, Seeger RC, Schwab M, Varmus HE, Bishop JM. 1984. Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science 224: 1121-1124.
13. Brodeur GM, Pritchard J, Berthold F, Carlsen NL, Castel V, Castelberry RP, De Bernardi B, Evans A, Favrot M, Hedborg F. 1993. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol 11: 1466-1477.
14. Bryan TM, Englezou A, Dalla-Pozza L, Dunham MA, Reddel RR. 1997. Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines. Nat Med 3: 1271-1274.
15. Capper R, Britt-Compton B, Tankimanova M, Rowson J, Letsolo B, Man S, Haughton M, Baird DM. 2007. The nature of telomere fusion and a definition of the critical telomere length in human cells. Genes Dev 21: 2495-2508.
16. Cerone MA, Londono-Vallejo JA, Bacchetti S. 2001. Telomere maintenance by telomerase and by recombination can coexist in human cells. Hum Mol Genet 10: 1945-1952.
17. Chan SR, Blackburn EH. 2004. Telomeres and telomerase. Philos Trans R Soc Lond B Biol Sci 359: 109-121.
18. Coquelle A, Pipiras E, Toledo F, Buttin G, Debatisse M. 1997. Expression of fragile sites triggers intrachromosomal mammalian gene amplification and sets boundaries to early amplicons. Cell 89: 215-225.
19. de Lange T. 2005. Shelterin: The protein complex that shapes and safeguards human telomeres. Genes Dev 19: 2100-2110.
20. Donaldson L, Fordyce C, Gilliland F, Smith A, Feddersen R, Joste N, Moyzis R, Griffith J. 1999. Association between outcome and telomere DNA content in prostate cancer. J Urol 162: 1788-1792.
21. Draskovic I, Arnoult N, Steiner V, Bacchetti S, Lomonte P, Londono-Vallejo A. 2009. Probing PML body function in ALT cells reveals spatiotemporal requirements for telomere recombination. Proc Natl Acad Sci U S A 106: 15726-15731.
22. Feldser D, Strong MA, Greider CW. 2006. Ataxia telangiectasia mutated (Atm) is not required for telomerase-mediated elongation of short telomeres. Proc Natl Acad Sci U S A 103: 2249-2251.
23. Ferlicot S, Youssef N, Feneux D, Delhommeau F, Paradis V, Bedossa P. 2003. Measurement of telomere length on tissue sections using quantitative fluorescence in situ hybridization (Q-FISH). J Pathol 200: 661-666.
24. Fordyce CA, Heaphy CM, Bisoffi M, Wyaco JL, Joste NE, Mangalik A, Baumgartner KB, Baumgartner RN, Hunt WC, Griffith JK. 2006. Telomere content correlates with stage and prognosis in breast cancer. Breast Cancer Res Treat 99: 193-202.
25. Frías C, García-Aranda C, De Juan C, Morán A, Ortega P, Gómez A, Hernando F, López-Asenjo JA, Torres AJ, Benito M, Iniesta P. 2008. Telomere shortening is associated with poor prognosis and telomerase activity correlates with DNA repair impairment in non-small cell lung cancer. Lung Cancer 60: 416-425.
26. Gisselsson D, Hoglund M. 2005. Connecting mitotic instability and chromosome aberrations in cancer-Can telomeres bridge the gap? Semin Cancer Biol 15: 13-23.
27. Gisselsson D, Jonson T, Petersen A, Strombeck B, Dal Cin P, Hoglund M, Mitelman F, Mertens F, Mandahl N. 2001. Telomere dysfunction triggers extensive DNA fragmentation and evolution of complex chromosome abnormalities in human malignant tumors. Proc Natl Acad Sci U S A 98: 12683-12688.
28. Guiducci C, Cerone MA, Bacchetti S. 2001. Expression of mutant telomerase in immortal telomerase-negative human cells results in cell cycle deregulation, nuclear and chromosomal abnormalities and rapid loss of viability. Oncogene 20: 714-725.
29. Gunderson KL, Steemers FJ, Lee G, Mendoza LG, Chee MS. 2005. A genome-wide scalable SNP genotyping assay using microarray technology. Nat Genet 37: 549-554.
30. Hiyama E, Hiyama K, Yokoyama T, Ichikawa T, Matsuura Y. 1992. Length of telomeric repeats in neuroblastoma: Correlation with prognosis and other biological characteristics. Jpn J Cancer Res 83: 159-164.
31. London WB, Castleberry RP, Matthay KK, Look AT, Seeger RC, Shimada H, Thorner P, Brodeur G, Maris JM, Reynolds CP, Cohn SL. 2005. Evidence for an age cutoff greater than 365 days for neuroblastoma risk group stratification in the Children's Oncology Group. J Clin Oncol 23: 6459-6465.
32. McClintock B. 1938. The production of homozygous deficient tissues with mutant characteristics by means of the aberrant mitotic behavior of ring-shaped chromosomes. Genetics 23: 315-376.
33. Meeker AK, Argani P. 2004. Telomere shortening occurs early during breast tumorigenesis: A cause of chromosome destabilization underlying malignant transformation? J Mammary Gland Biol Neoplasia 9: 285-296.
34. Meeker AK, Gage WR, Hicks JL, Simon I, Coffman JR, Platz EA, March GE, De Marzo AM. 2002. Telomere length assessment in human archival tissues: Combined telomere fluorescence in situ hybridization and immunostaining. Am J Pathol 160: 1259-1268.
35. Narath R, Ambros IM, Kowalska A, Bozsaky E, Boukamp P, Ambros PF. 2007. Induction of senescence in MYCN amplified neuroblastoma cell lines by hydroxyurea. Genes Chromosomes Cancer 46: 130-142.
36. O'sullivan JN, Finley JC, Risques RA, Shen WT, Gollahon KA, Moskovitz AH, Gryaznov S, Harley CB, Rabinovitch PS. 2004. Telomere length assessment in tissue sections by quantitative FISH: Image analysis algorithms. Cytometry A 58: 120-131.
37. Ohali A, Avigad S, Ash S, Goshen Y, Luria D, Feinmesser M, Zaizov R, Yaniv I. 2006. Telomere length is a prognostic factor in neuroblastoma. Cancer 107: 1391-1399.
38. Ohyashiki JH, Iwama H, Yahata N, Ando K, Hayashi S, Shay JW, Ohyashiki K. 1999. Telomere stability is frequently impaired in high-risk groups of patients with myelodysplastic syndromes. Clin Cancer Res 5: 1155-1160.
39. Onitake Y, Hiyama E, Kamei N, Yamaoka H, Sueda T, Hiyama K. 2009. Telomere biology in neuroblastoma: Telomere binding proteins and alternative strengthening of telomeres. J Pediatr Surg 44: 2258-2266.
40. Poon SS, Martens UM, Ward RK, Lansdorp PM. 1999. Telomere length measurements using digital fluorescence microscopy. Cytometry 36: 267-278.
41. Scheel C, Schaefer KL, Jauch A, Keller M, Wai D, Brinkschmidt C, van Valen F, Boecker W, Dockhorn-Dworniczak B, Poremba C. 2001. Alternative lengthening of telomeres is associated with chromosomal instability in osteosarcomas. Oncogene 20: 3835-3844.
42. Slack A, Chen Z, Tonelli R, Pule M, Hunt L, Pession A, Shohet JM. 2005. The p53 regulatory gene MDM2 is a direct transcriptional target of MYCN in neuroblastoma. Proc Natl Acad Sci U S A 102: 731-736.
43. Srivatsan ES, Murali V, Seeger RC. 1991. Loss of heterozygosity for alleles on chromosomes 11q and 14q in neuroblastoma. Prog Clin Biol Res 366: 91-98.
44. Staaf J, Lindgren D, Vallon-Christersson J, Isaksson A, Goransson H, Juliusson G, Rosenquist R, Hoglund M, Borg A, Ringner M. 2008. Segmentation-based detection of allelic imbalance and loss-of-heterozygosity in cancer cells using whole genome SNP arrays. Genome Biol 9: R136.
45. Steemers FJ, Chang W, Lee G, Barker DL, Shen R, Gunderson KL. 2006. Whole-genome genotyping with the single-base extension assay. Nat Methods 3: 31-33.
46. Stewenius Y, Gorunova L, Jonson T, Larsson N, Hoglund M, Mandahl N, Mertens F, Mitelman F, Gisselsson D. 2005. Structural and numerical chromosome changes in colon cancer develop through telomere-mediated anaphase bridges, not through mitotic multipolarity. Proc Natl Acad Sci U S A 102: 5541-5546.
47. Swiggers SJ, Kuijpers MA, de Cort MJ, Beverloo HB, Zijlmans JM. 2006. Critically short telomeres in acute myeloid leukemia with loss or gain of parts of chromosomes. Genes Chromosomes Cancer 45: 247-256.
48. Ulaner GA. 2004. Telomere maintenance in clinical medicine. Am J Med 117: 262-269.
49. Ulaner GA, Huang HY, Otero J, Zhao Z, Ben-Porat L, Satagopan JM, Gorlick R, Meyers P, Healey JH, Huvos AG, Hoffman AR, Ladanyi M. 2003. Absence of a telomere maintenance mechanism as a favorable prognostic factor in patients with osteosarcoma. Cancer Res 63: 1759-1763.
50. von Zglinicki T. 2002. Oxidative stress shortens telomeres. Trends Biochem Sci 27: 339-344.
51. Wesbuer S, Lanvers-Kaminsky C, Duran-Seuberth I, Bolling T, Schafer KL, Braun Y, Willich N, Greve B. 2010. Association of telomerase activity with radio- and chemosensitivity of neuroblastomas. Radiat Oncol 5: 66.
52. Wise JL, Crout RJ, McNeil DW, Weyant RJ, Marazita ML, Wenger SL. 2009. Human telomere length correlates to the size of the associated chromosome arm. PLoS One 4: e6013.
53. Wu KJ, Grandori C, Amacker M, Simon-Vermot N, Polack A, Lingner J, Dalla-Favera R. 1999. Direct activation of TERT transcription by c-MYC. Nat Genet 21: 220-224.